Arrhythmia Diagnosis and Treatment: Brady‑ and Tachyarrhythmias

•

 61 min video

•

 11 min read

YouTube video ID: -n_ciSV3oDE

Source: YouTube video by Ninja Nerd — Watch original video

PDF

Arrhythmias are broadly categorized into two types: bradyarrhythmias (heart rate too slow) and tachyarrhythmias (heart rate too fast). Understanding their pathophysiology, diagnosis, and treatment is crucial.

Bradyarrhythmias

Bradyarrhythmias are characterized by a heart rate typically below 60 beats per minute (BPM), though a rate below 50 BPM is often considered more clinically concerning. They are primarily divided into sinus bradycardia and AV blocks.

Sinus Bradycardia

Sinus bradycardia results from a dysfunction of the sinoatrial (SA) node, which fails to generate action potentials at an adequate rate. This leads to decreased electrical conduction to the ventricles and a low ventricular rate.

Causes of SA Node Dysfunction:

  • Nodal Blockers:
    • Beta-blockers (e.g., metoprolol, carvedilol, labetalol): Overdose blocks beta-1 receptors, preventing calcium influx and depolarization. Glucagon is the antidote.
    • Calcium Channel Blockers (e.g., verapamil, diltiazem): Overdose blocks calcium channels, preventing calcium influx and depolarization. Calcium is the antidote.
    • Digoxin: Increases acetylcholine, activating muscarinic 2 receptors, causing potassium efflux and hyperpolarization, thus decreasing heart rate. Digibind is the antidote for toxicity.
  • Hyperkalemia: Potassium levels reaching 6-7 mEq/L can inactivate sodium channels by increasing the resting membrane potential, preventing depolarization. ECG findings include peaked T waves, prolonged PR interval, and wide QRS complexes, potentially progressing to a sine wave pattern or V-fib/PEA arrest. Calcium stabilizes cardiac membranes.
  • High Vagal Tone: Neurological catastrophes (e.g., subarachnoid hemorrhage, traumatic brain injury with increased intracranial pressure) can trigger vagus nerve activity. The vagus nerve releases acetylcholine, which acts on muscarinic 2 receptors, causing potassium efflux and hyperpolarization, similar to digoxin. This can be part of Cushing's Triad (bradycardia, hypertension, irregular breathing).
  • Decreased Sympathetic Tone (Hypothyroidism/Myxedema): In severe hypothyroidism, beta-1 receptors become less sensitive to norepinephrine and epinephrine, reducing calcium influx and depolarization. Patients may also present with hypothermia and integumentary dysfunction (myxedema). Thyroid function tests (low T3/T4, abnormal TSH) are diagnostic.

AV Blocks

AV node block occurs when the SA node fires normally, but the AV node fails to conduct electrical activity efficiently to the ventricles, leading to a low ventricular rate (heart rate < 50 BPM).

Causes of AV Node Dysfunction:

  • Same as SA Node Dysfunction: All causes of SA node dysfunction (beta-blocker overdose, calcium channel blocker overdose, digoxin overdose, hyperkalemia, hypothyroidism, neurological catastrophes) can also affect the AV node.
  • Nodal Destruction:
    • Inferior Myocardial Infarction (MI): Occlusion of the right coronary artery can infarct the right ventricle and the AV node, impairing conduction. Patients present with angina, troponin elevation, and ST elevation in leads II, III, aVF.
    • Lyme Carditis: Severe Lyme disease infection can affect the AV node, potentially leading to third-degree AV block. A "bullseye" rash may be present. Treatment is ceftriaxone for carditis.
    • Old Age (Senile Fibrosis): Age-related fibrosis of the AV node is a common cause.

Tachyarrhythmias

Tachyarrhythmias are characterized by a heart rate typically above 100 BPM. They can originate from the atria (supraventricular tachyarrhythmias) or the ventricles (ventricular tachyarrhythmias).

Pathophysiological Mechanisms of Tachyarrhythmias

Three primary mechanisms drive tachyarrhythmias:

  1. Enhanced Automaticity:
    • Enhanced Normal Automaticity: The SA node fires faster than normal, increasing conduction through the entire system.
    • Enhanced Abnormal Automaticity: An ectopic focus in the atria or ventricles fires rapidly.
    • Mechanism: Usually due to increased sympathetic tone (norepinephrine/epinephrine release), stimulating beta-1 receptors, causing calcium influx, depolarization, and increased conduction.
  2. Re-entrant Circuits:
    • Atrial Re-entry: A "circus movement" of electrical activity within the atria, often due to atrial remodeling (heterogeneity in tissue makeup) caused by pressure or volume overload (e.g., CHF, hypertension, mitral stenosis).
    • Ventricular Re-entry: A "circus movement" within the ventricles, often due to ventricular remodeling (fibrotic scar from MI, or stretching from systolic heart failure with reduced ejection fraction < 35%).
  3. Triggered Activity:
    • Ectopic foci fire undesirably due to depolarizations occurring before complete repolarization.
    • Early Afterdepolarizations (EADs): Occur during the repolarization phase, often due to prolonged QT interval (e.g., hypokalemia, hypomagnesemia, certain drugs).
    • Delayed Afterdepolarizations (DADs): Occur after repolarization is complete but before the next normal depolarization, usually due to excessive calcium influx (e.g., high sympathetic tone, MI, digoxin toxicity).

Types of Tachyarrhythmias

  • Sinus Tachycardia: Primarily driven by increased automaticity due to increased sympathetic tone.
    • Causes: Hypotension (cardiogenic, obstructive, septic, hypovolemic shock), hypoxemia (PaO2 < 60 mmHg, low O2 saturation, PE, pneumonia, severe COPD exacerbation, severe anemia), hyperthyroidism (thyroid storm, increased beta-1 sensitivity, increased metabolic rate), fever, sympathomimetic drugs (albuterol, norepinephrine, epinephrine, cocaine, methamphetamine), pheochromocytoma, pain, anxiety.
  • Multifocal Atrial Tachycardia (MAT): Primarily due to enhanced automaticity, often caused by chronic hypoxemia, especially in COPD patients or those using theophylline.
  • Paroxysmal Supraventricular Tachycardia (PSVT): Primarily due to re-entry, often anatomical.
    • AV Nodal Re-entrant Tachycardia (AVNRT): A re-entrant circuit within the AV node due to two pathways (slow and fast) created by fibrosis, leading to rapid conduction. P-waves may be absent or retrograde.
    • Wolff-Parkinson-White (WPW) Syndrome (AV Re-entrant Tachycardia): An accessory pathway (Bundle of Kent) bypasses the AV node, allowing direct conduction from atria to ventricles. Dangerous if atrial fibrillation occurs, as it can lead to V-fib. ECG triad: decreased PR interval, wide QRS complex, Delta wave.
  • Atrial Flutter & Atrial Fibrillation: A combination of mechanisms.
    • Re-entrant Circuits: Atrial flutter often involves the cavotricuspid isthmus. Atrial fibrillation involves multiple re-entrant circuits, often around the pulmonary vein entries. These are often due to atrial remodeling from chronic conditions (hypertension, CHF, mitral valve stenosis).
    • Triggers: Increased sympathetic tone (hypotension, hypoxemia, hyperthyroidism, fever, sympathomimetic drugs) and triggered activity (EADs from hypokalemia, hypomagnesemia, QT prolongation).
  • Ventricular Tachycardia (VT) & Ventricular Fibrillation (VFib): Usually a combination of mechanisms.
    • Re-entrant Circuits: Ventricular remodeling (fibrotic scar from MI, or stretching from systolic heart failure) creates heterogeneity.
    • Triggers: Increased sympathetic tone (hypotension, hypoxemia, hyperthyroidism, fever, sympathomimetic drugs) and triggered activity (EADs from hypokalemia, hypomagnesemia; DADs from MI, digoxin toxicity).
    • VT: Can be monomorphic (one ectopic focus, uniform QRS) or polymorphic (multiple foci, varying QRS).
    • VFib: Multiple chaotic re-entrant circuits.
  • Torsades de Pointes: Primarily due to triggered activity (EADs).
    • Causes: Hypokalemia, hypomagnesemia, and QT-prolonging medications (antiarrhythmics like amiodarone, sotalol; antibiotics like macrolides; antipsychotics like haloperidol; antidepressants like SSRIs, TCAs; antiemetics like ondansetron, compazine). ECG shows a polymorphic VT with a "ribbon-like" appearance, preceded by a prolonged QT interval.

Unstable Arrhythmias

An arrhythmia is considered unstable if it causes symptoms of organ hypoperfusion.

Features of Instability:

  • Altered Mental Status: Due to poor brain perfusion (syncope, confusion, lethargy, obtundation).
  • Angina: Due to poor myocardial perfusion (myocardial ischemia).
  • Acute Heart Failure/Pulmonary Edema: Due to backflow into pulmonary veins/alveoli (severe dyspnea, hypoxia).
  • Hypotension/Shock: Systolic BP < 90 mmHg, diastolic BP < 60 mmHg, or MAP < 65 mmHg. Shock is hypotension requiring inotropes/vasopressors, often with elevated lactate or cold/pale/mottled extremities.

Mechanism of Instability:

  • Bradycardia: Directly drops cardiac output (CO = HR x SV).
  • Tachycardia (HR > 150 BPM): Reduces diastolic filling time, decreasing ventricular filling, preload, stroke volume, and thus cardiac output.
  • Result: Decreased cardiac output leads to decreased blood pressure (BP = CO x SVR), causing organ hypoperfusion.

Cardiac Arrest

Cardiac arrest is the most severe complication, characterized by no cardiac output and no pulse.

Types of Cardiac Arrest Rhythms:

  • Pulseless Electrical Activity (PEA): Organized rhythm on ECG but no pulse. Non-shockable.
  • Asystole: Flatline on ECG, no pulse. Non-shockable.
  • Ventricular Tachycardia (VT) without a pulse: Wide, regular tachycardia. Shockable.
  • Ventricular Fibrillation (VFib): Wide, irregular, erratic rhythm. Shockable.

H's and T's (Reversible Causes of Cardiac Arrest):

  • H's: Hypoxia, Hypovolemia, Hypothermia, Hypo/Hyperkalemia, Hydrogen ion (acidosis).
  • T's: Tamponade (cardiac), Tension pneumothorax, Thrombosis (coronary/pulmonary), Toxins.
    • Addressing these underlying causes (e.g., oxygen, fluids, bicarbonate, calcium, warming, pericardiocentesis, chest tube, thrombolytics, antidotes) is critical during resuscitation.

Diagnostic Approach

Bradyarrhythmias

  1. Obtain ECG:
  2. Assess for Sinus Rhythm:
    • Upright P-wave in lead II, inverted in aVR.
    • QRS complex after every P-wave.
    • Normal PR interval (160-200 ms, < 1 large box).
    • If all true, it's Sinus Bradycardia.
  3. Assess for AV Block (if not sinus bradycardia):
    • First-Degree AV Block: Prolonged PR interval (> 200 ms), but no dropped QRS complexes.
    • Second-Degree Mobitz Type I (Wenckebach): PR interval progressively lengthens, then a QRS complex is dropped.
    • Second-Degree Mobitz Type II: PR interval is constant, but QRS complexes are randomly dropped.
    • Third-Degree AV Block (Complete Heart Block): Complete AV dissociation; P-waves and QRS complexes beat independently with no relationship. Often wide QRS (infranodal block).

Tachyarrhythmias

  1. Obtain ECG:
  2. Assess QRS Width:
    • Narrow QRS (< 120 ms, < 3 small boxes): Supraventricular tachycardia.
    • Wide QRS (> 120 ms, > 3 small boxes): Ventricular tachycardia or SVT with aberrancy.
  3. Assess R-R Interval (for narrow QRS):
    • Narrow Regular Tachycardia:
      • Sinus Tachycardia: Upright P in lead II, inverted in aVR, P followed by QRS.
      • PSVT: No P-waves or retrograde P-waves. Often responds to vagal maneuvers or adenosine.
      • 2:1 Atrial Flutter: Flutter waves (sawtooth pattern) in leads II, III, aVF.
    • Narrow Irregular Tachycardia:
      • Atrial Fibrillation: Fibrillatory waves (chaotic baseline) in V1, irregularly irregular R-R interval.
      • Multifocal Atrial Tachycardia (MAT): Three or more morphologically different P-waves.
  4. Assess R-R Interval (for wide QRS):
    • Wide Regular Tachycardia:
      • Ventricular Tachycardia (Monomorphic): Wide QRS complexes with similar morphology. Treat as VT until proven otherwise.
      • PSVT with Aberrancy: PSVT with a bundle branch block, making it appear wide. Difficult to differentiate from VT.
    • Wide Irregular Tachycardia:
      • Ventricular Fibrillation: Wide, erratic, irregular rhythm.
      • Torsades de Pointes: Polymorphic VT preceded by prolonged QT interval, with a characteristic "ribbon-like" appearance.
      • Atrial Fibrillation with Aberrancy: Atrial fibrillation with a bundle branch block.

Treatment

Bradyarrhythmias

Unstable Symptomatic Bradycardia (HR < 50 BPM with instability features):

  1. Atropine: 0.5-1 mg IV push. Blocks muscarinic 2 receptors, increasing heart rate. May fail in infranodal AV blocks (wide QRS).
  2. If Atropine Fails:
    • Epinephrine: 2-10 mcg/min infusion (or bolus if severe). Hits beta-1 receptors.
    • Alternative Infusions: Isoproterenol (pure beta-1 agonist), Dopamine.
  3. Transcutaneous Pacing (TCP): Apply pads and pace the heart electrically. Provide pain medicine and sedation.
  4. Transvenous Pacing: Insert a temporary pacemaker wire into the heart via a central line.
  5. Permanent Pacemaker: For long-term management once stable.
  6. Treat Underlying Cause: (e.g., antidote for overdose, calcium for hyperkalemia, thyroid hormone for hypothyroidism, revascularization for MI, ceftriaxone for Lyme carditis).

Tachyarrhythmias

Stable Tachyarrhythmias (no instability features):

  • PSVT:
    1. Vagal Maneuvers: Bear down (Valsalva) to increase vagal tone and block AV node.
    2. Adenosine: 6 mg IV push, then 12 mg if needed. Shuts down AV node to reset heart.
    3. Long-term Prevention: Beta-blockers (metoprolol, carvedilol) or calcium channel blockers (diltiazem, verapamil).
    4. Refractory: Electrophysiology (EP) study and radiofrequency ablation (burn abnormal pathways).
  • Atrial Flutter & Atrial Fibrillation:
    1. Rate Control (often preferred): Beta-blockers (metoprolol, carvedilol), calcium channel blockers (diltiazem, verapamil), digoxin (if other agents fail).
    2. Rhythm Control (if rate control fails or desired): Antiarrhythmics like amiodarone (for heart failure) or sotalol (for CAD).
    3. Refractory: EP study and radiofrequency ablation (burn re-entrant circuits around pulmonary veins or cavotricuspid isthmus).
    4. Treat Underlying Cause: (e.g., electrolytes, sympathetic tone, etc.).
  • Ventricular Tachycardia (Monomorphic, stable):
    1. Rhythm Control: Amiodarone (for heart failure), Lidocaine (if MI suspected).
    2. Prevention: Beta-blockers.
    3. Recurrent/High Risk: EP study for implantable cardioverter-defibrillator (ICD) placement.
  • Torsades de Pointes:
    1. Discontinue QT-prolonging medications.
    2. Correct Electrolytes: Give potassium, and most importantly, Magnesium (4g IV).
    3. Recurrent/Long QT Syndrome: EP study for ICD placement.
  • Sinus Tachycardia & Multifocal Atrial Tachycardia: Treat the underlying cause (e.g., hypotension, hypoxemia, hyperthyroidism, fever, COPD, theophylline). No specific antiarrhythmic medications are typically used for these.

Unstable Tachyarrhythmias (HR > 100 BPM with instability features):

  1. Immediate Electrical Therapy: Do not waste time with medications.
  2. Synchronized Cardioversion: For atrial flutter, atrial fibrillation, PSVT, or VT with a pulse. The defibrillator syncs with the R-wave to deliver a shock.
  3. Defibrillation (Unsynchronized Shock): For Torsades de Pointes (AED cannot reliably track R-waves) or pulseless VT/VFib.

Cardiac Arrest Treatment

Pulseless Electrical Activity (PEA) or Asystole:

  1. Initiate CPR: High-quality chest compressions are paramount for organ perfusion.
  2. IV/IO Access: For medication administration.
  3. Attach Pads: To assess rhythm.
  4. Rhythm/Pulse Check (every 2 minutes):
    • If Pulse Present (ROSC): Assess for command following. If not following commands or myoclonic seizures, initiate targeted temperature management (therapeutic hypothermia).
    • If No Pulse:
      • Non-shockable Rhythm (PEA/Asystole): Give Epinephrine 1 mg IV, resume CPR.
      • Address H's and T's: (Hypoxia, Hypovolemia, Hypothermia, Hypo/Hyperkalemia, Acidosis, Tamponade, Tension pneumothorax, Thrombosis, Toxins).

Ventricular Tachycardia (VT) without a pulse or Ventricular Fibrillation (VFib):

  1. Initiate CPR: High-quality chest compressions.
  2. IV/IO Access:
  3. Attach Pads:
  4. Rhythm/Pulse Check (every 2 minutes):
    • If Pulse Present (ROSC): Assess for command following. If not following commands or myoclonic seizures, initiate targeted temperature management.
    • If No Pulse:
      • Shockable Rhythm (VT/VFib): Defibrillate.
      • Give Epinephrine 1 mg IV, resume CPR.
      • Next Rhythm/Pulse Check (if still VT/VFib): Defibrillate again. Consider Amiodarone (300 mg IV bolus, then 150 mg) as an alternative to epinephrine.
      • Address H's and T's.

Understanding the complex interplay of these mechanisms and their clinical manifestations is essential for effective diagnosis and management of arrhythmias.

  Takeaways

  • Bradyarrhythmias are defined by heart rates below 60 BPM, with sinus bradycardia and AV blocks caused by SA/AV node dysfunction, drug overdoses, hyperkalemia, high vagal tone, or hypothyroidism.
  • AV block can result from inferior myocardial infarction, Lyme carditis, or age‑related fibrosis, and presents with prolonged PR intervals or dissociated P‑waves and QRS complexes on ECG.
  • Tachyarrhythmias arise from enhanced automaticity, re‑entrant circuits, or triggered activity, leading to conditions such as sinus tachycardia, PSVT, atrial flutter/fibrillation, ventricular tachycardia, and torsades de pointes.
  • Unstable arrhythmias cause organ hypoperfusion manifested by altered mental status, angina, acute heart failure, or hypotension, and require immediate electrical therapy or pharmacologic support.
  • Management includes specific drugs (atropine, epinephrine, adenosine, beta‑blockers, calcium, magnesium) and interventions (transcutaneous pacing, synchronized cardioversion, defibrillation, pacemaker or ICD implantation) tailored to the rhythm and stability.

Frequently Asked Questions

What is the antidote for beta‑blocker overdose in sinus bradycardia?

Glucagon is the antidote for beta‑blocker overdose causing sinus bradycardia. It stimulates adenylate cyclase via Gs receptors, increasing intracellular cAMP and calcium influx, which restores SA node automaticity and improves heart rate. It is given intravenously in a bolus followed by infusion.

How does hyperkalemia cause bradyarrhythmia on the ECG?

Hyperkalemia induces bradyarrhythmia by raising the resting membrane potential, which inactivates sodium channels and slows depolarization. On ECG this appears as peaked T waves, a prolonged PR interval, widened QRS complexes, and in severe cases a sine‑wave pattern that can progress to ventricular fibrillation.

Who is Ninja Nerd on YouTube?

Ninja Nerd is a YouTube channel that publishes videos on a range of topics. Browse more summaries from this channel below.

Does this page include the full transcript of the video?

Yes, the full transcript for this video is available on this page. Click 'Show transcript' in the sidebar to read it.

Helpful resources related to this video

If you want to practice or explore the concepts discussed in the video, these commonly used tools may help.

Links may be affiliate links. We only include resources that are genuinely relevant to the topic.

Full transcript is not shown on this page

This page focuses on the summary and original notes. For full verification, refer to the original YouTube video.

PDF